Genzyme Corp. v. Atrium Medical Corp.
108 F. App'x 619
Opinion
ORDER
Atrium Medical Corporation moves to dismiss these appeals as premature. Atrium states that Genzyme Corporation et al. does not oppose.
Accordingly,
IT IS ORDERED THAT:
(1) The appeals are dismissed as premature.
(2) Each side shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Genzyme Corp. v. Atrium Medical Corp., 108 F. App'x 619 (Fed. Cir. 2004).
108 F. App'x 619 (Genzyme Corp. v. Atrium Medical Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.